beta
Trial Radar AI

Showing clinical trials matching location: Texas, San Antonio.

I can help you find nearby clinical trials and understand health conditions and treatments.
13 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Location
Texas, San Antonio
×
 
Study Type
Interventional
×
 
Intervention
GLP-1
×
 
Study Title
Status
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM) NCT06446531
Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US NCT07431086
Recruiting
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults NCT06811324
Recruiting
Avexitide for Treatment of Post-Bariatric Hypoglycemia (LUCIDITY) NCT06747468
Active, not recruiting
The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery NCT07212868
Recruiting
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial NCT07505303
Not yet recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) NCT07165028
Recruiting
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight (TOGETHER-PsO) NCT06588283
Active, not recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor NCT06221969
Active, not recruiting
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-2) NCT06962280
Active, not recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight (COMMIT-CD) NCT06937099
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study (COMMIT-UC) NCT06937086
Recruiting